Literature DB >> 24390987

Validation of quantitative fluorescent-PCR for rapid prenatal diagnosis of common aneuploidies in the Chinese population.

A-Q Xu1, M Xia, J-T Liu, F-X Yao, W-M Zhang, N Hao, J Zhou, X-M Bian.   

Abstract

Quantitative fluorescent polymerase chain reaction (QF-PCR) is an accurate and reliable method for rapid detection of aneuploidy; however, it is not routinely used in China. We aimed to validate QF-PCR as a means for prenatal common aneuploidy screening and to analyze the heterozygosities of short tandem repeat (STR) markers in the Chinese population. The sequences of 19 STR markers in chromosomes 21, 18, 13, X, and Y were designed; three kinds of fluoresceins were used to label the primers, and the QF-PCR detecting conditions were explored and optimized. The results of analysis of 210 prenatal samples by multiplex QF-PCR were compared with karyotyping analysis. All cases were successfully tested by QF-PCR and conventional cytogenetic analysis. QF-PCR results were consistent with the results of cytogenetic analyses, with the exception of two cases. The sensitivity and specificity of QF-PCR to diagnose common aneuploidies were 94.74 and 100%, respectively. The heterozygosities of most of the markers were lower than reported for Western populations, but relatively similar to those of other Asian populations. We conclude that QF-PCR is able to detect the common aneuploidies for prenatal diagnosis with high detection efficacy; therefore it is suitable for rapid prenatal diagnosis and for large-scale testing in laboratories. However, we need to add new STR markers or to find alternative STR markers with high heterozygosity in order to make this technique useful for routine diagnosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24390987     DOI: 10.4238/2013.December.9.1

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  1 in total

1.  Validation of QF-PCR for prenatal diagnoses in a Brazilian population.

Authors:  Renata Wendel de Moraes; Mario Henrique Burlacchini de Carvalho; Antonio Gomes de Amorim-Filho; Rossana Pulcineli Vieira Francisco; Renata Moscolini Romão; José Eduardo Levi; Marcelo Zugaib
Journal:  Clinics (Sao Paulo)       Date:  2017-07       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.